Onset and Spread of Dyskinesias and Motor Symptoms in Parkinson's DiseaseFABBRINI, Giovanni; DEFAZIO, Giovanni; COLOSIMO, Carlo et al.Movement disorders. 2009, Vol 24, Num 14, pp 2091-2096, issn 0885-3185, 6 p.Article

Placebo Influences on Dyskinesia in Parkinson's DiseaseGOETZ, Christopher G; LASKA, Eugene; HICKING, Christine et al.Movement disorders. 2008, Vol 23, Num 5, pp 700-707, issn 0885-3185, 8 p.Article

Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesiasPAILLE, Vincent; HENRY, Vincent; LESCAUDRON, Laurent et al.Movement disorders. 2007, Vol 22, Num 4, pp 533-539, issn 0885-3185, 7 p.Article

Chronic metoclopramide therapy for diabetic gastroparesisLATA, Paul F; PIGARELLI, Denise L.The Annals of pharmacotherapy. 2003, Vol 37, Num 1, pp 122-126, issn 1060-0280, 5 p.Article

Nicotine and Parkinson's Disease : Implications for TherapyQUIK, Maryka; O'LEARY, Kathryn; TANNER, Caroline M et al.Movement disorders. 2008, Vol 23, Num 12, pp 1641-1652, issn 0885-3185, 12 p.Article

Elevated plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with dyskinesiasZOCCOLELLA, Stefano; LAMBERTI, Paolo; LIVREA, Paolo et al.Clinical chemistry and laboratory medicine. 2006, Vol 44, Num 7, pp 863-866, issn 1434-6621, 4 p.Article

Role of surgery in the treatment of motor complicationsMETMAN, Leo Verhagen; O'LEARY, Shaun T.Movement disorders. 2005, Vol 20, pp S45-S56, issn 0885-3185, SUP11Article

Pattern of levodopa-induced striatal changes is different in normal and MPTP-lesioned miceGROSS, Christian E; RAVENSCROFT, Paula; DOVERO, Sandra et al.Journal of neurochemistry. 2003, Vol 84, Num 6, pp 1246-1255, issn 0022-3042, 10 p.Article

FOLLOW-UP STUDY ON THE REVERSIBILITY OF TARDIVE DYSKINESIAWEGNER JT; KANE JM.1982; AM. J. PSYCHIATRY; ISSN 0002-953X; USA; DA. 1982; VOL. 139; NO 3; PP. 368-369; BIBL. 8 REF.Article

Covert Dyskinesia Associated With Aripiprazole: A Case Report and Review of the LiteratureMOSELEY, Carrie N; SIMPSON-KHANNA, Heather A; CATALANO, Glenn et al.Clinical neuropharmacology. 2013, Vol 36, Num 4, pp 128-130, issn 0362-5664, 3 p.Article

AFQ056 Treatment of Levodopa-Induced Dyskinesias: Results of 2 Randomized Controlled TrialsBERG, Daniela; GODAU, Jana; WOLZ, Martin et al.Movement disorders. 2011, Vol 26, Num 7, pp 1243-1250, issn 0885-3185, 8 p.Article

Stimulation of subthalamic fibre tracts reduces dyskinesias in STN-DBSHERZOG, J; PINSKER, M; WASNER, M et al.Movement disorders. 2007, Vol 22, Num 5, pp 679-684, issn 0885-3185, 6 p.Article

Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's diseaseALONSO-FRECH, F; ZAMARBIDE, I; ALEGRE, M et al.Brain. 2006, Vol 129, pp 1748-1757, issn 0006-8950, 10 p., 7Article

Mirtazapine in L-dopa-induced dyskinesiasMECO, Giuseppe; FABRIZIO, Edito; DI REZZE, Simone et al.Clinical neuropharmacology. 2003, Vol 26, Num 4, pp 179-181, issn 0362-5664, 3 p.Article

Butaperazine pharmacokinetics in tardive dyskinesiaWOLF, M. E; JAVAID, J. I; MOSNAIM, A. D et al.Biopharmaceutics & drug disposition. 1985, Vol 6, Num 2, pp 223-227, issn 0142-2782Article

Prolonged metoclopramide-induced dyskinetic reactionLEOPOLD, N. A.Neurology. 1984, Vol 34, Num 2, pp 238-239, issn 0028-3878Article

Formant frequency fluctuation as an index of motor steadiness in the vocal tractGERRATT, B. R.Journal of speech and hearing research. 1983, Vol 26, Num 2, pp 297-304, issn 0022-4685Article

Glutamate NMDA receptor dysregulation in Parkinson's disease with dyskinesiasAHMED, Imtiaz; BOSE, Subrata K; PAVESE, Nicola et al.Brain. 2011, Vol 134, pp 979-986, issn 0006-8950, 8 p., 4Article

Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's diseaseRODRIGUEZ-OROZ, Maria C; LOPEZ-AZCARATE, Jon; GARCIA-GARCIA, David et al.Brain. 2011, Vol 134, pp 36-49, issn 0006-8950, 14 p., 1Article

Frequency-specific effects of stimulation of the subthalamic area in treated Parkinson's disease patientsKÜHN, Andrea A; FOGELSON, Noa; DOWSEY LIMOUSIN, Patricia et al.Neuroreport (Oxford). 2009, Vol 20, Num 11, pp 975-978, issn 0959-4965, 4 p.Article

The Clinical Relevance of Levodopa Toxicity in the Treatment of Parkinson's DiseaseSCHAPIRA, Anthony H. V.Movement disorders. 2008, Vol 23, issn 0885-3185, S515-S520, SUP3Article

Treatment of Levodopa-Induced Motor ComplicationsSTOCCHI, Fabrizio; TAGLIATI, Michele; OLANOW, C. Warren et al.Movement disorders. 2008, Vol 23, issn 0885-3185, S599-S612, SUP3Article

Levodopa-induced dyskinesias and their managementDEL SORBO, Francesca; ALBANESE, Alberto.Journal of neurology. 2008, Vol 255, pp 32-41, issn 0340-5354, 10 p., SUP4Conference Paper

Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease : A prospective study using single-dose challengesKATZENSCHLAGER, Regina; HUGHES, Andrew; EVANS, Andrew et al.Movement disorders. 2005, Vol 20, Num 2, pp 151-157, issn 0885-3185, 7 p.Article

Molindone and haloperidol in tardive dyskinesiaGLAZER, W. M; HAFEZ, H. M; BENARROCHE, C. L et al.The Journal of clinical psychiatry. 1985, Vol 46, Num 8, pp 4-7, issn 0160-6689Article